Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Adipocytokine signaling pathway 💬 16 genes, 38 drugs (DrugBank) and 104 diseases |
TNF [1] TNF 💬Adipocytokine signaling pathway
|
Adalimumab Adalimumab 💬Adipocytokine signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬1. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | African trypanosomiasis 💬 10 genes, 24 drugs (DrugBank) and 62 diseases |
TNF [1] TNF 💬African trypanosomiasis
|
Adalimumab Adalimumab 💬African trypanosomiasis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬2. African trypanosomiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
TNF [1] TNF 💬AGE-RAGE signaling pathway in diabetic complications
|
Adalimumab Adalimumab 💬AGE-RAGE signaling pathway in diabetic complications
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬3. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | Alcoholic liver disease 💬 42 genes, 54 drugs (DrugBank) and 91 diseases |
TNF [1] TNF 💬Alcoholic liver disease
|
Adalimumab Adalimumab 💬Alcoholic liver disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬4. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | Allograft rejection 💬 31 genes, 26 drugs (DrugBank) and 60 diseases |
TNF [1] TNF 💬Allograft rejection
|
Adalimumab Adalimumab 💬Allograft rejection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬5. Allograft rejection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Alzheimer disease
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬6. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Alzheimer disease
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬6. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
TNF [1] TNF 💬Alzheimer disease
|
Adalimumab Adalimumab 💬Alzheimer disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬8. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 71 diseases |
TNF [1] TNF 💬Amoebiasis
|
Adalimumab Adalimumab 💬Amoebiasis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬9. Amoebiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Amphetamine addiction
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬10. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Amphetamine addiction
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬10. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Amyotrophic lateral sclerosis
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬12. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Amyotrophic lateral sclerosis
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬13. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
TNF [1] TNF 💬Amyotrophic lateral sclerosis
|
Adalimumab Adalimumab 💬Amyotrophic lateral sclerosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬14. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 | Antigen processing and presentation 💬 26 genes, 17 drugs (DrugBank) and 61 diseases |
TNF [1] TNF 💬Antigen processing and presentation
|
Adalimumab Adalimumab 💬Antigen processing and presentation
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬15. Antigen processing and presentation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 | Apoptosis 💬 17 genes, 31 drugs (DrugBank) and 64 diseases |
TNF [1] TNF 💬Apoptosis
|
Adalimumab Adalimumab 💬Apoptosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬16. Apoptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | Asthma 💬 21 genes, 25 drugs (DrugBank) and 58 diseases |
TNF [1] TNF 💬Asthma
|
Adalimumab Adalimumab 💬Asthma
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬17. Asthma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 75 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Axon guidance
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬18. Axon guidance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 75 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Axon guidance
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬18. Axon guidance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 | B cell receptor signaling pathway 💬 19 genes, 39 drugs (DrugBank) and 68 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬B cell receptor signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬20. B cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 | B cell receptor signaling pathway 💬 19 genes, 39 drugs (DrugBank) and 68 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬B cell receptor signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬20. B cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 | C-type lectin receptor signaling pathway 💬 27 genes, 66 drugs (DrugBank) and 102 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬C-type lectin receptor signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬22. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 | C-type lectin receptor signaling pathway 💬 27 genes, 66 drugs (DrugBank) and 102 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬C-type lectin receptor signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬23. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 | C-type lectin receptor signaling pathway 💬 27 genes, 66 drugs (DrugBank) and 102 diseases |
TNF [1] TNF 💬C-type lectin receptor signaling pathway
|
Adalimumab Adalimumab 💬C-type lectin receptor signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬24. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Calcium signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬25. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
26 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Calcium signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬25. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Cellular senescence
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬27. Cellular senescence
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
28 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Cellular senescence
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬28. Cellular senescence
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
29 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬cGMP-PKG signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬29. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
30 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬cGMP-PKG signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬30. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31 | Chagas disease 💬 31 genes, 56 drugs (DrugBank) and 87 diseases |
TNF [1] TNF 💬Chagas disease
|
Adalimumab Adalimumab 💬Chagas disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬31. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
32 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
TNF [1] TNF 💬Coronavirus disease - COVID-19
|
Adalimumab Adalimumab 💬Coronavirus disease - COVID-19
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬32. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
TNF [1] TNF 💬Cytokine-cytokine receptor interaction
|
Adalimumab Adalimumab 💬Cytokine-cytokine receptor interaction
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬33. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
34 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
TNF [1] TNF 💬Dilated cardiomyopathy
|
Adalimumab Adalimumab 💬Dilated cardiomyopathy
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬34. Dilated cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
35 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
PPP3C [3] PPP3C, PPP3C, PPP3C 💬
|
Tacrolimus Tacrolimus 💬Dopaminergic synapse
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬35. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
36 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
PPP3C [3] PPP3C, PPP3C, PPP3C 💬
|
Tacrolimus Tacrolimus 💬Dopaminergic synapse
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬35. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37 | Epstein-Barr virus infection 💬 67 genes, 90 drugs (DrugBank) and 82 diseases |
TNF [1] TNF 💬Epstein-Barr virus infection
|
Adalimumab Adalimumab 💬Epstein-Barr virus infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬37. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
38 | Fc epsilon RI signaling pathway 💬 19 genes, 50 drugs (DrugBank) and 68 diseases |
TNF [1] TNF 💬Fc epsilon RI signaling pathway
|
Adalimumab Adalimumab 💬Fc epsilon RI signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬38. Fc epsilon RI signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
39 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
TNF [1] TNF 💬Fluid shear stress and atherosclerosis
|
Adalimumab Adalimumab 💬Fluid shear stress and atherosclerosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬39. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
40 | Glucagon signaling pathway 💬 14 genes, 23 drugs (DrugBank) and 82 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Glucagon signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬40. Glucagon signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
41 | Glucagon signaling pathway 💬 14 genes, 23 drugs (DrugBank) and 82 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Glucagon signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬41. Glucagon signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
42 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Glutamatergic synapse
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬42. Glutamatergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Glutamatergic synapse
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬43. Glutamatergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
44 | Graft-versus-host disease 💬 28 genes, 25 drugs (DrugBank) and 64 diseases |
TNF [1] TNF 💬Graft-versus-host disease
|
Adalimumab Adalimumab 💬Graft-versus-host disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬44. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
TNF [1] TNF 💬Hematopoietic cell lineage
|
Adalimumab Adalimumab 💬Hematopoietic cell lineage
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬45. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
46 | Hepatitis B 💬 43 genes, 65 drugs (DrugBank) and 87 diseases |
TNF [1] TNF 💬Hepatitis B
|
Adalimumab Adalimumab 💬Hepatitis B
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬46. Hepatitis B
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
47 | Hepatitis C 💬 36 genes, 70 drugs (DrugBank) and 87 diseases |
TNF [1] TNF 💬Hepatitis C
|
Adalimumab Adalimumab 💬Hepatitis C
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬47. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
48 | Herpes simplex virus 1 infection 💬 70 genes, 80 drugs (DrugBank) and 107 diseases |
TNF [1] TNF 💬Herpes simplex virus 1 infection
|
Adalimumab Adalimumab 💬Herpes simplex virus 1 infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬48. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
49 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Human cytomegalovirus infection
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬49. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
50 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Human cytomegalovirus infection
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬50. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
51 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
TNF [1] TNF 💬Human cytomegalovirus infection
|
Adalimumab Adalimumab 💬Human cytomegalovirus infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬51. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
52 | Human immunodeficiency virus 1 infection 💬 50 genes, 57 drugs (DrugBank) and 95 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Human immunodeficiency virus 1 infection
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬52. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
53 | Human immunodeficiency virus 1 infection 💬 50 genes, 57 drugs (DrugBank) and 95 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Human immunodeficiency virus 1 infection
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬53. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
54 | Human immunodeficiency virus 1 infection 💬 50 genes, 57 drugs (DrugBank) and 95 diseases |
TNF [1] TNF 💬Human immunodeficiency virus 1 infection
|
Adalimumab Adalimumab 💬Human immunodeficiency virus 1 infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬54. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
55 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
TNF [1] TNF 💬Human papillomavirus infection
|
Adalimumab Adalimumab 💬Human papillomavirus infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬55. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
56 | Human T-cell leukemia virus 1 infection 💬 59 genes, 74 drugs (DrugBank) and 96 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Human T-cell leukemia virus 1 infection
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬56. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
57 | Human T-cell leukemia virus 1 infection 💬 59 genes, 74 drugs (DrugBank) and 96 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Human T-cell leukemia virus 1 infection
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬57. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
58 | Human T-cell leukemia virus 1 infection 💬 59 genes, 74 drugs (DrugBank) and 96 diseases |
TNF [1] TNF 💬Human T-cell leukemia virus 1 infection
|
Adalimumab Adalimumab 💬Human T-cell leukemia virus 1 infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬58. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
59 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
TNF [1] TNF 💬Hypertrophic cardiomyopathy
|
Adalimumab Adalimumab 💬Hypertrophic cardiomyopathy
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬59. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
60 | IL-17 signaling pathway 💬 20 genes, 61 drugs (DrugBank) and 86 diseases |
TNF [1] TNF 💬IL-17 signaling pathway
|
Adalimumab Adalimumab 💬IL-17 signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬60. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
61 | Inflammatory bowel disease 💬 37 genes, 46 drugs (DrugBank) and 70 diseases |
TNF [1] TNF 💬Inflammatory bowel disease
|
Adalimumab Adalimumab 💬Inflammatory bowel disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬61. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
62 | Influenza A 💬 65 genes, 78 drugs (DrugBank) and 98 diseases |
TNF [1] TNF 💬Influenza A
|
Adalimumab Adalimumab 💬Influenza A
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬62. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
63 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 100 diseases |
TNF [1] TNF 💬Insulin resistance
|
Adalimumab Adalimumab 💬Insulin resistance
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬63. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
64 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Kaposi sarcoma-associated herpesvirus infection
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬64. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
65 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Kaposi sarcoma-associated herpesvirus infection
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬65. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
66 | Legionellosis 💬 9 genes, 23 drugs (DrugBank) and 64 diseases |
TNF [1] TNF 💬Legionellosis
|
Adalimumab Adalimumab 💬Legionellosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬66. Legionellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
67 | Leishmaniasis 💬 40 genes, 68 drugs (DrugBank) and 102 diseases |
TNF [1] TNF 💬Leishmaniasis
|
Adalimumab Adalimumab 💬Leishmaniasis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬67. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
68 | Lipid and atherosclerosis 💬 51 genes, 71 drugs (DrugBank) and 103 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Lipid and atherosclerosis
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬68. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
69 | Lipid and atherosclerosis 💬 51 genes, 71 drugs (DrugBank) and 103 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Lipid and atherosclerosis
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬68. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
70 | Lipid and atherosclerosis 💬 51 genes, 71 drugs (DrugBank) and 103 diseases |
TNF [1] TNF 💬Lipid and atherosclerosis
|
Adalimumab Adalimumab 💬Lipid and atherosclerosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬70. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
71 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Long-term potentiation
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬71. Long-term potentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
72 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Long-term potentiation
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬71. Long-term potentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
73 | Malaria 💬 16 genes, 32 drugs (DrugBank) and 71 diseases |
TNF [1] TNF 💬Malaria
|
Adalimumab Adalimumab 💬Malaria
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬73. Malaria
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
74 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬MAPK signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬74. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
75 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬MAPK signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬75. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
76 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
TNF [1] TNF 💬MAPK signaling pathway
|
Adalimumab Adalimumab 💬MAPK signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬76. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
77 | mTOR signaling pathway 💬 14 genes, 33 drugs (DrugBank) and 95 diseases |
TNF [1] TNF 💬mTOR signaling pathway
|
Adalimumab Adalimumab 💬mTOR signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬77. mTOR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
78 | Natural killer cell mediated cytotoxicity 💬 44 genes, 50 drugs (DrugBank) and 86 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Natural killer cell mediated cytotoxicity
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬78. Natural killer cell mediated cytotoxicity
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
79 | Natural killer cell mediated cytotoxicity 💬 44 genes, 50 drugs (DrugBank) and 86 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Natural killer cell mediated cytotoxicity
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬79. Natural killer cell mediated cytotoxicity
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
80 | Natural killer cell mediated cytotoxicity 💬 44 genes, 50 drugs (DrugBank) and 86 diseases |
TNF [1] TNF 💬Natural killer cell mediated cytotoxicity
|
Adalimumab Adalimumab 💬Natural killer cell mediated cytotoxicity
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬80. Natural killer cell mediated cytotoxicity
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
81 | Necroptosis 💬 32 genes, 52 drugs (DrugBank) and 77 diseases |
TNF [1] TNF 💬Necroptosis
|
Adalimumab Adalimumab 💬Necroptosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬81. Necroptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
82 | NF-kappa B signaling pathway 💬 22 genes, 77 drugs (DrugBank) and 91 diseases |
TNF [1] TNF 💬NF-kappa B signaling pathway
|
Adalimumab Adalimumab 💬NF-kappa B signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬82. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
83 | NOD-like receptor signaling pathway 💬 32 genes, 51 drugs (DrugBank) and 74 diseases |
TNF [1] TNF 💬NOD-like receptor signaling pathway
|
Adalimumab Adalimumab 💬NOD-like receptor signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬83. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
84 | Non-alcoholic fatty liver disease 💬 23 genes, 52 drugs (DrugBank) and 95 diseases |
TNF [1] TNF 💬Non-alcoholic fatty liver disease
|
Adalimumab Adalimumab 💬Non-alcoholic fatty liver disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬84. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
85 | Oocyte meiosis 💬 14 genes, 39 drugs (DrugBank) and 77 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Oocyte meiosis
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬85. Oocyte meiosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
86 | Oocyte meiosis 💬 14 genes, 39 drugs (DrugBank) and 77 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Oocyte meiosis
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬86. Oocyte meiosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
87 | Osteoclast differentiation 💬 38 genes, 86 drugs (DrugBank) and 102 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Osteoclast differentiation
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬87. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
88 | Osteoclast differentiation 💬 38 genes, 86 drugs (DrugBank) and 102 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Osteoclast differentiation
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬88. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
89 | Osteoclast differentiation 💬 38 genes, 86 drugs (DrugBank) and 102 diseases |
TNF [1] TNF 💬Osteoclast differentiation
|
Adalimumab Adalimumab 💬Osteoclast differentiation
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬89. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
90 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Oxytocin signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬90. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
91 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Oxytocin signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬91. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
92 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
TNF [1] TNF 💬Pathogenic Escherichia coli infection
|
Adalimumab Adalimumab 💬Pathogenic Escherichia coli infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬92. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
93 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Pathways of neurodegeneration - multiple diseases
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬93. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
94 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Pathways of neurodegeneration - multiple diseases
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬93. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
95 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
TNF [1] TNF 💬Pathways of neurodegeneration - multiple diseases
|
Adalimumab Adalimumab 💬Pathways of neurodegeneration - multiple diseases
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬95. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
96 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 35 genes, 66 drugs (DrugBank) and 100 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬96. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
97 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 35 genes, 66 drugs (DrugBank) and 100 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬96. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
98 | Pertussis 💬 22 genes, 46 drugs (DrugBank) and 73 diseases |
TNF [1] TNF 💬Pertussis
|
Adalimumab Adalimumab 💬Pertussis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬98. Pertussis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
99 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Prion disease
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬99. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
100 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Prion disease
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬100. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
101 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
TNF [1] TNF 💬Prion disease
|
Adalimumab Adalimumab 💬Prion disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬101. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
102 | Proteoglycans in cancer 💬 33 genes, 73 drugs (DrugBank) and 103 diseases |
TNF [1] TNF 💬Proteoglycans in cancer
|
Adalimumab Adalimumab 💬Proteoglycans in cancer
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬102. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
103 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Renin secretion
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬103. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
104 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Renin secretion
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬104. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
105 | Rheumatoid arthritis 💬 38 genes, 59 drugs (DrugBank) and 87 diseases |
TNF [1] TNF 💬Rheumatoid arthritis
|
Adalimumab Adalimumab 💬Rheumatoid arthritis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬105. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
106 | RIG-I-like receptor signaling pathway 💬 24 genes, 20 drugs (DrugBank) and 57 diseases |
TNF [1] TNF 💬RIG-I-like receptor signaling pathway
|
Adalimumab Adalimumab 💬RIG-I-like receptor signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
107 | Salmonella infection 💬 30 genes, 46 drugs (DrugBank) and 75 diseases |
TNF [1] TNF 💬Salmonella infection
|
Adalimumab Adalimumab 💬Salmonella infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬107. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
108 | Shigellosis 💬 29 genes, 51 drugs (DrugBank) and 92 diseases |
TNF [1] TNF 💬Shigellosis
|
Adalimumab Adalimumab 💬Shigellosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬108. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
109 | Sphingolipid signaling pathway 💬 32 genes, 57 drugs (DrugBank) and 80 diseases |
TNF [1] TNF 💬Sphingolipid signaling pathway
|
Adalimumab Adalimumab 💬Sphingolipid signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬109. Sphingolipid signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
110 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 83 diseases |
TNF [1] TNF 💬Systemic lupus erythematosus
|
Adalimumab Adalimumab 💬Systemic lupus erythematosus
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬110. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
111 | T cell receptor signaling pathway 💬 38 genes, 59 drugs (DrugBank) and 84 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬T cell receptor signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬111. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
112 | T cell receptor signaling pathway 💬 38 genes, 59 drugs (DrugBank) and 84 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬T cell receptor signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬111. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
113 | T cell receptor signaling pathway 💬 38 genes, 59 drugs (DrugBank) and 84 diseases |
TNF [1] TNF 💬T cell receptor signaling pathway
|
Adalimumab Adalimumab 💬T cell receptor signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬113. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
114 | TGF-beta signaling pathway 💬 14 genes, 27 drugs (DrugBank) and 65 diseases |
TNF [1] TNF 💬TGF-beta signaling pathway
|
Adalimumab Adalimumab 💬TGF-beta signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬114. TGF-beta signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
115 | Th1 and Th2 cell differentiation 💬 46 genes, 51 drugs (DrugBank) and 77 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Th1 and Th2 cell differentiation
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬115. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
116 | Th1 and Th2 cell differentiation 💬 46 genes, 51 drugs (DrugBank) and 77 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Th1 and Th2 cell differentiation
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬115. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
117 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Th17 cell differentiation
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬117. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
118 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Th17 cell differentiation
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬118. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
119 | TNF signaling pathway 💬 23 genes, 61 drugs (DrugBank) and 90 diseases |
TNF [1] TNF 💬TNF signaling pathway
|
Adalimumab Adalimumab 💬TNF signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬119. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
120 | Toll-like receptor signaling pathway 💬 41 genes, 65 drugs (DrugBank) and 79 diseases |
TNF [1] TNF 💬Toll-like receptor signaling pathway
|
Adalimumab Adalimumab 💬Toll-like receptor signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬120. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
121 | Toxoplasmosis 💬 41 genes, 49 drugs (DrugBank) and 76 diseases |
TNF [1] TNF 💬Toxoplasmosis
|
Adalimumab Adalimumab 💬Toxoplasmosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬121. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
122 | Tuberculosis 💬 66 genes, 73 drugs (DrugBank) and 98 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Tuberculosis
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬122. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
123 | Tuberculosis 💬 66 genes, 73 drugs (DrugBank) and 98 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Tuberculosis
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬123. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
124 | Tuberculosis 💬 66 genes, 73 drugs (DrugBank) and 98 diseases |
TNF [1] TNF 💬Tuberculosis
|
Adalimumab Adalimumab 💬Tuberculosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬124. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
125 | Type I diabetes mellitus 💬 32 genes, 25 drugs (DrugBank) and 70 diseases |
TNF [1] TNF 💬Type I diabetes mellitus
|
Adalimumab Adalimumab 💬Type I diabetes mellitus
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬125. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
126 | Type II diabetes mellitus 💬 14 genes, 42 drugs (DrugBank) and 94 diseases |
TNF [1] TNF 💬Type II diabetes mellitus
|
Adalimumab Adalimumab 💬Type II diabetes mellitus
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬126. Type II diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
127 | VEGF signaling pathway 💬 23 genes, 56 drugs (DrugBank) and 94 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬VEGF signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬127. VEGF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
128 | VEGF signaling pathway 💬 23 genes, 56 drugs (DrugBank) and 94 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬VEGF signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬128. VEGF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
129 | Viral protein interaction with cytokine and cytokine receptor 💬 17 genes, 32 drugs (DrugBank) and 68 diseases |
TNF [1] TNF 💬Viral protein interaction with cytokine and cytokine receptor
|
Adalimumab Adalimumab 💬Viral protein interaction with cytokine and cytokine receptor
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬129. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
130 | Wnt signaling pathway 💬 10 genes, 11 drugs (DrugBank) and 59 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Wnt signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬130. Wnt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
131 | Wnt signaling pathway 💬 10 genes, 11 drugs (DrugBank) and 59 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Tacrolimus Tacrolimus 💬Wnt signaling pathway
| Tacrolimus | 002 [33] 2 , 6 , 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬131. Wnt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
132 | Yersinia infection 💬 27 genes, 45 drugs (DrugBank) and 79 diseases |
TNF [1] TNF 💬Yersinia infection
|
Adalimumab Adalimumab 💬Yersinia infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬132. Yersinia infection
|
Adipocytokine signaling pathway
16 genes, 38 drugs (DrugBank) and 104 diseases
African trypanosomiasis
10 genes, 24 drugs (DrugBank) and 62 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 55 drugs (DrugBank) and 96 diseases
Alcoholic liver disease
42 genes, 54 drugs (DrugBank) and 91 diseases
Allograft rejection
31 genes, 26 drugs (DrugBank) and 60 diseases
Alzheimer disease
59 genes, 132 drugs (DrugBank) and 129 diseases
Amoebiasis
20 genes, 32 drugs (DrugBank) and 71 diseases
Amphetamine addiction
25 genes, 58 drugs (DrugBank) and 92 diseases
Amyotrophic lateral sclerosis
38 genes, 55 drugs (DrugBank) and 109 diseases
Antigen processing and presentation
26 genes, 17 drugs (DrugBank) and 61 diseases
Apoptosis
17 genes, 31 drugs (DrugBank) and 64 diseases
Asthma
21 genes, 25 drugs (DrugBank) and 58 diseases
Axon guidance
22 genes, 26 drugs (DrugBank) and 75 diseases
B cell receptor signaling pathway
19 genes, 39 drugs (DrugBank) and 68 diseases
C-type lectin receptor signaling pathway
27 genes, 66 drugs (DrugBank) and 102 diseases
Calcium signaling pathway
86 genes, 214 drugs (DrugBank) and 143 diseases
Cellular senescence
34 genes, 46 drugs (DrugBank) and 96 diseases
cGMP-PKG signaling pathway
49 genes, 132 drugs (DrugBank) and 124 diseases
Chagas disease
31 genes, 56 drugs (DrugBank) and 87 diseases
Coronavirus disease - COVID-19
54 genes, 108 drugs (DrugBank) and 105 diseases
Cytokine-cytokine receptor interaction
89 genes, 142 drugs (DrugBank) and 110 diseases
Dilated cardiomyopathy
24 genes, 61 drugs (DrugBank) and 88 diseases
Dopaminergic synapse
31 genes, 102 drugs (DrugBank) and 104 diseases
Epstein-Barr virus infection
67 genes, 90 drugs (DrugBank) and 82 diseases
Fc epsilon RI signaling pathway
19 genes, 50 drugs (DrugBank) and 68 diseases
Fluid shear stress and atherosclerosis
34 genes, 59 drugs (DrugBank) and 93 diseases
Glucagon signaling pathway
14 genes, 23 drugs (DrugBank) and 82 diseases
Glutamatergic synapse
23 genes, 30 drugs (DrugBank) and 81 diseases
Graft-versus-host disease
28 genes, 25 drugs (DrugBank) and 64 diseases
Hematopoietic cell lineage
53 genes, 95 drugs (DrugBank) and 101 diseases
Hepatitis B
43 genes, 65 drugs (DrugBank) and 87 diseases
Hepatitis C
36 genes, 70 drugs (DrugBank) and 87 diseases
Herpes simplex virus 1 infection
70 genes, 80 drugs (DrugBank) and 107 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
Human immunodeficiency virus 1 infection
50 genes, 57 drugs (DrugBank) and 95 diseases
Human papillomavirus infection
51 genes, 106 drugs (DrugBank) and 115 diseases
Human T-cell leukemia virus 1 infection
59 genes, 74 drugs (DrugBank) and 96 diseases
Hypertrophic cardiomyopathy
27 genes, 57 drugs (DrugBank) and 90 diseases
IL-17 signaling pathway
20 genes, 61 drugs (DrugBank) and 86 diseases
Inflammatory bowel disease
37 genes, 46 drugs (DrugBank) and 70 diseases
Influenza A
65 genes, 78 drugs (DrugBank) and 98 diseases
Insulin resistance
19 genes, 38 drugs (DrugBank) and 100 diseases
Kaposi sarcoma-associated herpesvirus infection
60 genes, 94 drugs (DrugBank) and 118 diseases
Legionellosis
9 genes, 23 drugs (DrugBank) and 64 diseases
Leishmaniasis
40 genes, 68 drugs (DrugBank) and 102 diseases
Lipid and atherosclerosis
51 genes, 71 drugs (DrugBank) and 103 diseases
Long-term potentiation
18 genes, 36 drugs (DrugBank) and 86 diseases
Malaria
16 genes, 32 drugs (DrugBank) and 71 diseases
MAPK signaling pathway
65 genes, 98 drugs (DrugBank) and 109 diseases
mTOR signaling pathway
14 genes, 33 drugs (DrugBank) and 95 diseases
Natural killer cell mediated cytotoxicity
44 genes, 50 drugs (DrugBank) and 86 diseases
Necroptosis
32 genes, 52 drugs (DrugBank) and 77 diseases
NF-kappa B signaling pathway
22 genes, 77 drugs (DrugBank) and 91 diseases
NOD-like receptor signaling pathway
32 genes, 51 drugs (DrugBank) and 74 diseases
Non-alcoholic fatty liver disease
23 genes, 52 drugs (DrugBank) and 95 diseases
Oocyte meiosis
14 genes, 39 drugs (DrugBank) and 77 diseases
Osteoclast differentiation
38 genes, 86 drugs (DrugBank) and 102 diseases
Oxytocin signaling pathway
35 genes, 80 drugs (DrugBank) and 110 diseases
Pathogenic Escherichia coli infection
28 genes, 43 drugs (DrugBank) and 78 diseases
Pathways of neurodegeneration - multiple diseases
63 genes, 138 drugs (DrugBank) and 132 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
35 genes, 66 drugs (DrugBank) and 100 diseases
Pertussis
22 genes, 46 drugs (DrugBank) and 73 diseases
Prion disease
41 genes, 74 drugs (DrugBank) and 114 diseases
Proteoglycans in cancer
33 genes, 73 drugs (DrugBank) and 103 diseases
Renin secretion
28 genes, 87 drugs (DrugBank) and 113 diseases
Rheumatoid arthritis
38 genes, 59 drugs (DrugBank) and 87 diseases
RIG-I-like receptor signaling pathway
24 genes, 20 drugs (DrugBank) and 57 diseases
Salmonella infection
30 genes, 46 drugs (DrugBank) and 75 diseases
Shigellosis
29 genes, 51 drugs (DrugBank) and 92 diseases
Sphingolipid signaling pathway
32 genes, 57 drugs (DrugBank) and 80 diseases
Systemic lupus erythematosus
30 genes, 49 drugs (DrugBank) and 83 diseases
T cell receptor signaling pathway
38 genes, 59 drugs (DrugBank) and 84 diseases
TGF-beta signaling pathway
14 genes, 27 drugs (DrugBank) and 65 diseases
Th1 and Th2 cell differentiation
46 genes, 51 drugs (DrugBank) and 77 diseases
Th17 cell differentiation
56 genes, 80 drugs (DrugBank) and 108 diseases
TNF signaling pathway
23 genes, 61 drugs (DrugBank) and 90 diseases
Toll-like receptor signaling pathway
41 genes, 65 drugs (DrugBank) and 79 diseases
Toxoplasmosis
41 genes, 49 drugs (DrugBank) and 76 diseases
Tuberculosis
66 genes, 73 drugs (DrugBank) and 98 diseases
Type I diabetes mellitus
32 genes, 25 drugs (DrugBank) and 70 diseases
Type II diabetes mellitus
14 genes, 42 drugs (DrugBank) and 94 diseases
VEGF signaling pathway
23 genes, 56 drugs (DrugBank) and 94 diseases
Viral protein interaction with cytokine and cytokine receptor
17 genes, 32 drugs (DrugBank) and 68 diseases
Wnt signaling pathway
10 genes, 11 drugs (DrugBank) and 59 diseases
Yersinia infection
27 genes, 45 drugs (DrugBank) and 79 diseases